InChIKey	SJFBTAPEPRWNKH-CCKFTAQKSA-N
Compound Name	Delanzomib
Canonical SMILES	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	6
Pfam Stratification	Cross-Family
Avg pChEMBL	8.23
Source	ChEMBL;BindingDB

DrugBank ID	DB11956
Drug Name	Delanzomib
CAS Number	847499-27-8
Groups	investigational
ATC Codes	nan
Description	Delanzomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, and Lymphoma, Non-Hodgkin.

---

Categories: Acids Acids, Noncarboxylic Amino Acids Amino Acids, Neutral Amino Acids, Peptides, and Proteins Boron Compounds Enzyme Inhibitors Protease Inhibitors Proteasome Inhibitors

---

Cross-references: BindingDB: 50329819 ChEBI: 141530 CHEMBL270515 ChemSpider: 23325665 PubChem:24800541 PubChem:347828281 ZINC: ZINC000169748228